Acologix

Acologix

Biopharmaceutical company developing therapeutic compounds for the treatment of osteo-renal diseases.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD185—278m (Dealroom.co estimates Feb 2006.)
Hayward California (HQ)
  • Edit
DateInvestorsAmountRound

$40.0m

Series B
N/A

$30.0m

Series C
Total FundingAUD108m

Recent News about Acologix

Edit